+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infectious Disease In vitro Diagnostics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application, End User, and Geography- Product Image
Infectious Disease In vitro Diagnostics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application, End User, and Geography- Product Image
New

Infectious Disease In vitro Diagnostics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application, End User, and Geography

  • PDF Icon

    Report

  • 190 Pages
  • July 2025
  • Region: Global
  • The Insight Partners
  • ID: 6114270
Description Jump to:
The infectious disease in vitro diagnostics market size is expected to grow from US$ 45.69 billion in 2024 to US$ 76.71 billion by 2031; it is projected to register a CAGR of 7.7% during 2025-2031. The increasing prevalence of infectious diseases and strategic developments by key players are noteworthy factors contributing to the expansion of the infectious disease in vitro diagnostics market size. However, the inadequate reimbursement scenario hinders the infectious disease in vitro diagnostics market growth.

Technological advancements involving the development and integration of molecular diagnostics and automation systems enhance the accuracy, speed, and accessibility of infectious disease detection. Below are a few instances:
  • In June 2024, MP Biomedicals introduced a new line of rapid immunochromatographic assays for Helicobacter pylori, Salmonella typhi, and Vibrio cholerae, intended for point-of-care in resource-constrained environments.
  • In June 2024, Roche gained FDA Emergency Use Authorization (EUA) for its cobas liat multiplex PCR panel updated to detect SARS-CoV-2, influenza A/B, and RSV simultaneously, advancing syndromic respiratory infection management in less than 20 minutes.
  • In July 2024, Sherlock Biosciences initiated clinical trials for its CRISPR-based over-the-counter (OTC) test for gonorrhea and chlamydia in May 2024, with an eye toward a 2025 launch. APEX-TB, integrating machine learning from AI and nanotechnology, was also launched to provide accurate, real-time molecular diagnostics using portable devices.
  • In June 2024, QIAGEN introduced 35 new wet-lab tested digital PCR Microbial DNA Detection Assays to its digital PCR (dPCR) platform QIAcuity, noticeably strengthening its capabilities in microbial research.
These advancements are part of a larger movement toward decentralized, user-centric, and fast diagnostic technologies guiding the future of infectious disease care. This is expected to contribute to the growth of the infectious disease in vitro diagnostics market in the coming years.

End User -Based Insights
Based on end user, the infectious disease in vitro diagnostics market is segmented into hospitals and clinics, diagnostics laboratories, blood bank, and others. The hospitals and clinics segment held the largest infectious disease in vitro diagnostics market share in 2024. The need for accurate, timely diagnosis in hospitals and clinics is rising steadily due to frequent outbreaks of Lassa fever, cholera, tuberculosis, and malaria. The soaring patient load and demand for quality care have pushed hospitals to adopt more sophisticated diagnostic tools, including molecular diagnostics.

Increased government funding, donor support, and infrastructure improvements in secondary and tertiary hospitals further boost the adoption of IVD products. Integrating IVD in hospital protocols improves patient outcomes, reduces unnecessary antibiotic use, and ensures better management of infectious diseases in urban and rural health centers, thereby fueling the infectious disease in vitro diagnostics market growth.

The World Health Organization and Mexico's Ministry of Health's National Institute of Respiratory Diseases are among the primary and secondary sources referred to while preparing the infectious disease in vitro diagnostics market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global infectious disease in vitro diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global infectious disease in vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Infectious Disease In vitro Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Infectious Disease In vitro Diagnostics Market - Key Market Dynamics
5.1 Infectious Disease In vitro Diagnostics Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Infectious Diseases
5.2.2 Strategic Developments by Key Players
5.3 Market Restraints
5.3.1 Inadequate Reimbursement Scenario
5.4 Market Opportunities
5.4.1 Government Initiatives to Increase Awareness Regarding Infectious Diseases
5.5 Future Trends
5.5.1 Technological Advancements
5.6 Impact of Drivers and Restraints:
6. Infectious Disease In vitro Diagnostics Market - Global Market Analysis
6.1 Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
6.2 Infectious Disease In vitro Diagnostics Market Forecast Analysis
7. Infectious Disease In vitro Diagnostics Market Analysis - by Applications
7.1 HIV or AIDS
7.1.1 Overview
7.1.2 HIV or AIDS: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Tuberculosis
7.2.1 Overview
7.2.2 Tuberculosis: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Hepatitis B and C
7.3.1 Overview
7.3.2 Hepatitis B and C: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Malaria
7.4.1 Overview
7.4.2 Malaria: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8. Infectious Disease In vitro Diagnostics Market Analysis - by End User
8.1 Hospitals and Clinics
8.1.1 Overview
8.1.2 Hospitals and Clinics: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Diagnostic Laboratories
8.2.1 Overview
8.2.2 Diagnostic Laboratories: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Blood Bank
8.3.1 Overview
8.3.2 Blood Bank: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9. Infectious Disease In vitro Diagnostics Market - Geographical Analysis
9.1 Overview
9.2 North America
9.2.1 North America Infectious Disease In vitro Diagnostics Market Overview
9.2.2 North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
9.2.2.1 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
9.2.2.2 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
9.2.3 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
9.2.3.1 United States: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2.3.1.1 United States: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.2.3.1.2 United States: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.2.3.2 Canada: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2.3.2.1 Canada: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.2.3.2.2 Canada: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.2.3.3 Mexico: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2.3.3.1 Mexico: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.2.3.3.2 Mexico: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.3 Europe
9.3.1 Europe Infectious Disease In vitro Diagnostics Market Overview
9.3.2 Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
9.3.2.1 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
9.3.2.2 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
9.3.3 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
9.3.3.1 United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3.3.1.1 United Kingdom: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.3.3.1.2 United Kingdom: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.3.3.2 Germany: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3.3.2.1 Germany: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.3.3.2.2 Germany: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.3.3.3 France: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3.3.3.1 France: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.3.3.3.2 France: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.3.3.4 Italy: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3.3.4.1 Italy: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.3.3.4.2 Italy: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.3.3.5 Spain: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3.3.5.1 Spain: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.3.3.5.2 Spain: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.3.3.6 Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3.3.6.1 Rest of Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.3.3.6.2 Rest of Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.4 Asia Pacific
9.4.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Overview
9.4.2 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
9.4.2.1 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
9.4.2.2 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
9.4.3 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
9.4.3.1 China: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4.3.1.1 China: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.4.3.1.2 China: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.4.3.2 Japan: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4.3.2.1 Japan: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.4.3.2.2 Japan: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.4.3.3 India: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4.3.3.1 India: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.4.3.3.2 India: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.4.3.4 Australia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4.3.4.1 Australia: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.4.3.4.2 Australia: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.4.3.5 South Korea: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4.3.5.1 South Korea: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.4.3.5.2 South Korea: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.4.3.6 Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4.3.6.1 Rest of APAC: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.4.3.6.2 Rest of APAC: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.5 Middle East and Africa
9.5.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market Overview
9.5.2 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
9.5.2.1 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
9.5.2.2 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
9.5.3 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
9.5.3.1 South Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5.3.1.1 South Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.5.3.1.2 South Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.5.3.2 Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5.3.2.1 Saudi Arabia: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.5.3.2.2 Saudi Arabia: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.5.3.3 United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5.3.3.1 United Arab Emirates: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.5.3.3.2 United Arab Emirates: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.5.3.4 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5.3.4.1 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.5.3.4.2 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.6 South and Central America
9.6.1 South and Central America Infectious Disease In vitro Diagnostics Market Overview
9.6.2 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
9.6.2.1 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
9.6.2.2 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
9.6.3 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
9.6.3.1 Brazil: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.6.3.1.1 Brazil: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.6.3.1.2 Brazil: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.6.3.2 Argentina: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.6.3.2.1 Argentina: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.6.3.2.2 Argentina: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
9.6.3.3 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.6.3.3.1 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
9.6.3.3.2 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.2 Company Positioning & Concentration
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
11.3 Organic Growth Strategies
112.3.1 Overview
11.4 Inorganic Growth Strategies
112.4.1 Overview
12. Company Profiles
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE LTD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BECTON DICKINSON AND CO
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SYSMEX CORP
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.5. BIOMERIEUX SA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIO-RAD LABORATORIES INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.6. QIAGEN NV
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.8. QUIDELORTHO CORP
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BRUKER CORP
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DANAHER CORP
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Infectious Disease In vitro Diagnostics Market Segmentation
Table 2. Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million)
Table 3. Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million)
Table 4. Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 5. Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 6. Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 7. Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 8. North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 9. North America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 10. North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 11. North America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 12. United States: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 13. United States: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 14. United States: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 15. United States: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 16. Canada: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 17. Canada: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 18. Canada: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 19. Canada: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 20. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 21. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 22. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 23. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 24. Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 25. Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 26. Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 27. Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 28. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 29. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 30. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 31. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 32. Germany: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 33. Germany: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 34. Germany: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 35. Germany: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 36. France: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 37. France: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 38. France: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 39. France: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 40. Italy: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 41. Italy: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 42. Italy: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 43. Italy: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 44. Spain: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 45. Spain: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 46. Spain: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 47. Spain: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 48. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 49. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 50. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 51. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 52. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 53. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 54. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 55. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 56. China: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 57. China: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 58. China: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 59. China: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 60. Japan: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 61. Japan: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 62. Japan: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 63. Japan: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 64. India: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 65. India: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 66. India: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 67. India: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 68. Australia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 69. Australia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 70. Australia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 71. Australia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 72. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 73. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 74. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 75. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 76. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 77. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 78. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 79. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 80. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 81. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 82. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 83. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 84. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 85. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 86. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 87. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 88. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 89. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 90. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 91. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 92. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 93. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 94. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 95. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 96. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 97. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 98. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 99. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 100. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 101. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 102. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 103. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 104. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 105. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 106. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 107. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 108. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 109. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 110. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 111. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 112. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
Table 113. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
Table 114. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 115. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 116. Heat Map Analysis by Key Players
Table 117. Recent Organic Growth Strategies in the global Infectious Disease In-Vitro Diagnostics Market
Table 118. Recent Inorganic Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
Table 119. Glossary of Terms, Infectious Disease In vitro Diagnostics Market
LIST OF FIGURES
Figure 1. Infectious Disease In vitro Diagnostics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
Figure 5. Infectious Disease In vitro Diagnostics Market Share (%) - by Applications (2024 and 2031)
Figure 6. HIV or AIDS: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Tuberculosis: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Hepatitis B and C: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Malaria: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Infectious Disease In vitro Diagnostics Market Share (%) - by End User (2024 and 2031)
Figure 12. Hospitals and Clinics: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Diagnostic Laboratories: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Blood Bank: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Infectious Disease In vitro Diagnostics Market Breakdown by Region, 2024 and 2031 (%)
Figure 17. North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
Figure 18. North America: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 19. United States: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 20. Canada: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 21. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 22. Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
Figure 23. Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 24. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 25. Germany: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 26. France: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 27. Italy: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 28. Spain: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 29. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 30. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
Figure 31. Asia Pacific: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 32. China: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 33. Japan: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 34. India: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 35. Australia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 36. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 37. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 38. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
Figure 39. Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 40. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 41. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 42. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 43. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 44. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
Figure 45. South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 46. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 47. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 48. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 49. Company Positioning & Concentration
Figure 50. Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market - Global Infectious Disease In vitro Diagnostics Market

Companies Mentioned

The List of Companies in the Infectious Disease In-vitro Diagnostics Market include:
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Becton Dickinson and Co
  • Sysmex Corp
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • QIAGEN NV
  • QuidelOrtho Corp
  • Bruker Corp.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJuly 2025
Forecast Period2024 - 2031
Estimated Market Value in 2024 45.69 Billion
Forecasted Market Value by 2031 76.71 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Nigeria Infectious Disease In-vitro Diagnostics Market Size and Forecast, Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application, End User, and Geography - Product Image

Nigeria Infectious Disease In-vitro Diagnostics Market Size and Forecast, Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application, End User, and Geography

  • Report
  • 89 Pages
  • Nigeria
From
Infectious Disease In vitro Diagnostics Market (2024 Edition): Analysis By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type, By End User, By Region, By Country: Market Insights and Forecast (2020-2030) - Product Image

Infectious Disease In vitro Diagnostics Market (2024 Edition): Analysis By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • 261 Pages
  • Global
From
Infectious Diseases in-Vitro Diagnostics Market by Test Type, Technology, Pathogen, End User, Application - Global Forecast to 2030 - Product Image

Infectious Diseases in-Vitro Diagnostics Market by Test Type, Technology, Pathogen, End User, Application - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
France In-Vitro Diagnostics Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis - Product Image

France In-Vitro Diagnostics Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

  • Report
  • 185 Pages
  • France
From
North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User - Product Image

North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

  • Report
  • 112 Pages
  • North America
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.